Adenocarcinoma of Esophagogastric Junction
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of Esophagogastric Junction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating perioperative chemotherapy plus trastuzumab and toripalimab for HER2-positive locally advanced gastric or …
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer [Phase 2]
Phase 2 trial investigating tucidinostat with a PD-1 inhibitor and bevacizumab in advanced esophageal and gastric cancers; status is current…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab plus neoadjuvant chemotherapy for locally advanced esophagogastric junction adenocarcinoma.